Comparison of Second-line Hepatic Arterial Infusion Chemotherapy and Tyrosine Kinase Inhibitors in Advanced Hepatocellular Carcinoma
Radiology · 01.08.2026 · 320 (2)
DOI: 10.1148/radiol.253280 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Radiology, erschienen am 01.08.2026. Verfasst von Jae-Sung Yoo und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Graduate School, Kyungpook National University, Daegu, Republic of Korea. Hauptthemen laut MEDLINE: Liver Neoplasms, Carcinoma, Hepatocellular, Protein Kinase Inhibitors, Antineoplastic Combined Chemotherapy Protocols. Die Arbeit nennt 34 Literaturangaben. Gefördert von: National Research Foundation of Korea, Ministry of Science and ICT, South Korea.
Themen: Onkologische Pflege
Abstract (Originalsprache)
In patients with advanced hepatocellular carcinoma, after atezolizumab-bevacizumab failure, second-line hepatic arterial infusion chemotherapy yielded higher response rates and longer progression-free survival than tyrosine kinase inhibitors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Medicine, Graduate School, Kyungpook National University, Daegu, Republic of Korea.
- The Catholic University Liver Research Center, Department of Biomedicine & Health Sciences, College of Medicine, The Catholic University of Korea, 222 Banpo-daero, Seocho-gu, Seoul 06591, Republic of Korea.
- Division of Gastroenterology and Hepatology, Department of Internal Medicine, Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul, Republic of Korea.
- Division of Gastroenterology and Hepatology, Department of Internal Medicine, Eunpyeong St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
- Division of Gastroenterology and Hepatology, Department of Internal Medicine, Uijeongbu St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Uijeongbu, Republic of Korea.
- Division of Gastroenterology and Hepatology, Department of Internal Medicine, Bucheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Bucheon, Republic of Korea.
ORCID-Profile: Jae-Sung Yoo, Kwon Yong Tak, Hee Sun Cho, Ji Won Han, Jaejun Lee, Hyun Yang, Chang Wook Kim, Suho Kim, Heechul Nam, Pil Soo Sung
Förderung
- National Research Foundation of Korea
- Ministry of Science and ICT, South Korea
Zitieren
APA
Yoo, J. S., Tak, K. Y., Cho, H. S., Han, J. W., Jang, J. W., Lee, J., Yang, H., Kim, C. W., Lee, H. L., Kim, H. Y., Kim, S., Oh, J. S., Chun, H. J., Nam, H., & Sung, P. S. (2026). Comparison of Second-line Hepatic Arterial Infusion Chemotherapy and Tyrosine Kinase Inhibitors in Advanced Hepatocellular Carcinoma. Radiology, 320(2). https://doi.org/10.1148/radiol.253280
Vancouver
Yoo JS, Tak KY, Cho HS, Han JW, Jang JW, Lee J, et al. Comparison of Second-line Hepatic Arterial Infusion Chemotherapy and Tyrosine Kinase Inhibitors in Advanced Hepatocellular Carcinoma. Radiology. 2026;320(2). doi:10.1148/radiol.253280
BibTeX
@article{Yoo2026,
author = {Yoo, Jae-Sung and Tak, Kwon Yong and Cho, Hee Sun and Han, Ji Won and Jang, Jeong Won and Lee, Jaejun and Yang, Hyun and Kim, Chang Wook and Lee, Hae Lim and Kim, Hee Yeon and Kim, Suho and Oh, Jung Suk and Chun, Ho Jong and Nam, Heechul and Sung, Pil Soo},
title = {Comparison of Second-line Hepatic Arterial Infusion Chemotherapy and Tyrosine Kinase Inhibitors in Advanced Hepatocellular Carcinoma},
journal = {Radiology},
year = {2026},
volume = {320},
number = {2},
doi = {10.1148/radiol.253280}
}
EUVIMED